Adma Biologics Inc Earnings

Adma Biologics Inc’s revenue jumped 12% since last year same period to $134.22Mn in the Q3 2025. On a quarterly growth basis, Adma Biologics Inc has generated 10.03% jump in its revenue since last 3-months.

Adma Biologics Inc’s net profit jumped 1.45% since last year same period to $36.43Mn in the Q3 2025. On a quarterly growth basis, Adma Biologics Inc has generated 6.46% jump in its net profits since last 3-months.

Adma Biologics Inc’s net profit margin fell -9.43% since last year same period to 27.14% in the Q3 2025. On a quarterly growth basis, Adma Biologics Inc has generated -3.25% fall in its net profit margins since last 3-months.

Adma Biologics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.18 - a 18.13% jump from last quarter’s estimates.

Adma Biologics Inc’s earning per share (EPS) estimates for the current year stand at 0.18.

Adma Biologics Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q4 2025. This indicates that the Adma Biologics Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.